Progress in Cytotoxicity of Biomaterials
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Biomedical Engineering and Materials".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 584
Special Issue Editor
Special Issue Information
Dear Colleagues,
The cytotoxicity of biomaterials is a critical aspect of biomedical research, influencing the safety, efficacy, and long-term biocompatibility of materials used in medical implants, drug delivery systems, and tissue engineering. This Special Issue aims to highlight recent advances in the evaluation of biomaterial cytotoxicity, including in vitro and in vivo testing methodologies, mechanisms of cellular interactions, and strategies to enhance biocompatibility. Topics of interest for this Special Issue include the role of surface modifications, nanomaterials, and biodegradable polymers in reducing cytotoxic effects, as well as emerging techniques for assessing cell viability, oxidative stress, and inflammatory responses. We invite contributions that provide insights into novel biomaterial designs, toxicity mitigation strategies, and regulatory considerations to ensure safe biomedical applications.
Dr. Lakkamraju Vijayalakshmi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomaterial cytotoxicity
- biocompatibility assessment
- in vitro and in vivo toxicity
- surface modification
- nanomaterials in medicine
- oxidative stress and inflammation
- tissue engineering materials
- drug delivery systems
- biodegradable polymers
- regulatory perspectives on biomaterial safety
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.